Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol., 13 November 2025

Sec. Epilepsy

Volume 16 - 2025 | https://doi.org/10.3389/fneur.2025.1658440

MRI-based radiomics model for differentiating focal cortical dysplasia from dysembryoplastic neuroepithelial tumor in epileptic children

Xinyi YangXinyi YangShuang DingShuang DingZhongxin HuangZhongxin HuangXiangmin ZhangXiangmin ZhangJinhua Cai
Jinhua Cai*
  • Department of Radiology, Children’s Hospital of Chongqing Medical University, Chongqing, China

Objective: Focal cortical dysplasia (FCD) and dysembryoplastic neuroepithelial tumor (DNET) are two major causes of intractable epilepsy, often with confusing imaging findings. This study aimed to develop magnetic resonance imaging (MRI)-based radiomics models for preoperative differentiation between FCD and DNET.

Methods: This study included 169 patients who underwent epilepsy surgery and were pathologically diagnosed with FCD (n = 96) or DNET (n = 73). Conventional brain T1-weighted (T1WI), T2-weighted (T2WI) and T2-fluid-attenuated inversion recovery (T2-FLAIR) images were acquired from all cases. The whole dataset was randomly divided into a training set and a test set at a ratio of 3:1. PyRadiomics software was used for feature extraction and selection. The final features were determined using the least absolute shrinkage and selection operator (LASSO) algorithm. A support vector machine (SVM) was used to establish radiomics models based on individual sequences or fusion of these sequences. The performance of each model was evaluated by the area under the receiver operating characteristic curve (AUC), and the optimal model was also compared with the radiologists’ assessment results.

Results: The fusion radiomics model exhibited the best performance in differentiating between FCD and DNET, with an AUC of 0.894 (95% CI: 0.799–0.968) and an accuracy of 82.0%, which were superior to the individual models based on T1WI, T2WI, or T2-FLAIR images. In addition, the diagnostic performance of the fusion radiomics model was superior to that of the junior radiologist and comparable to that of the senior radiologist.

Conclusion: The fusion radiomics model based on multi-sequence MRI can successfully differentiate FCD from DNET preoperatively, which contributes to appropriate surgical planning and satisfactory treatment outcomes.

1 Introduction

Focal cortical dysplasia (FCD) and dysembryoplastic neuroepithelial tumor (DNET) are the most common causes of medically intractable epilepsy in children (13). They both require surgical resection, which can help reduce epileptic seizures and improve cognitive outcomes. Nonetheless, previous studies have shown that the postoperative recurrence rate of seizures varies greatly between patients with FCD and DNET. After complete resection, about 80% of patients with DNET will no longer experience seizures, whereas 50% of patients with FCD will still develop seizures of varying degrees (4, 5). Research suggests that blurred histological boundaries of FCD lesions should be taken into account for the surgical resection. Therefore, electroencephalography is often recommended to determine the extent of cortical excision. In contrast, complete surgical resection of DNET and epileptogenic zone (EZ) is thought to be sufficient and effective for preventing postoperative seizures (6, 7). Given the different surgical strategies and prognosis between FCD and DNET, preoperative differential diagnosis is of great importance.

Previous studies have shown that the clinical manifestations of FCD and DNET are similar except that epilepsy occurs earlier in children with FCD than in children with DNET, which is not sufficient to differentiate between the two diseases (8). Although positron emission tomography (PET) with high sensitivity can help identify FCD and DNET, it tends to lack specificity to metabolic decline emerging in the interictal stage (9). At present, magnetic resonance imaging (MRI) has played an important role in the detection and diagnosis of FCD and DNET. Despite many MR scanning techniques and post-processing methods, the imaging features such as the location, shape and signal changes of the two diseases are similar, which may lead to misdiagnosis. To sum up, it is still difficult to differentiate FCD from DNET by the existing imaging methods. Therefore, it is essential to develop a more precise and impartial diagnostic technique to differentiate between the two diseases.

Radiomics generally aims to extract quantitative and ideally reproducible information from diagnostic images, including complex patterns that are difficult for the human eye to recognize or quantify (1012). By using the radiomics features, the radiomics models can be established to achieve predictions, judgments, and differential diagnosis of diseases (13). A support vector machine (SVM) is a powerful classification algorithm that can estimate the classification probabilities and control complexity, which has been widely used in the field of neuroimaging (1416), and also applied in related research on FCD (17). In addition, the least absolute shrinkage and selection operator (LASSO) is a regularization technique for minimizing the number of non-zero elements and producing a unique solution (18), which is often used to solve the problem of large sets of radiomics features derived from a relatively small sample size. Previously, it has been verified that LASSO combined with SVM has the best performance in differentiating diseases (19). Therefore, it is expected that the combination of the two can be used to differentiate FCD from DNET.

Therefore, this study aimed to develop radiomics models based on individual sequences (T1WI, T2WI, and T2-FLAIR) or fusion of these sequences for differentiating FCD from DNET, and compare their diagnostic performance. We hope to provide a new high-performance method for preoperative differentiation of FCD and DNET in children with drug-resistant epilepsy.

2 Methods

2.1 Participants

This retrospective study was approved by the Institutional Review Board of our hospital and the requirement to obtain written informed consent was waived. All participants were from the our hospital between January 2014 and December 2022. Inclusion criteria were as follows: (1) Patients diagnosed with epilepsy in accordance with the International League Against Epilepsy (ILAE) Guidelines for Classification and Diagnosis of Epilepsy (20), (2) those undergoing epilepsy surgery and pathologically diagnosed with FCD or DNET, pathological types of FCD include: type I and type II (specifically, subtypes Ia, Ib, Ic, IIa, and IIb according to the ILAE classification), (3) those receiving preoperative non-invasive evaluation, including long-term video-EEG, conventional MRI and PET-CT. Exclusion criteria included: (1) Patients with incomplete clinical data, (2) those with low imaging quality, (3) those with FCD who had any concomitant lesions, or (4) those with recurrent lesions or a history of treatment. The flowchart of patient selection is shown in Figure 1. The clinical data including gender, age, age at seizure onset, type of seizure (based on the new operational classification by the ILAE), past medical history (febrile convulsions, encephalitis, perinatal brain injury, and traumatic brain injury) and kinds of anti-seizure medication administered were recorded.

Figure 1
Flowchart detailing patient data selection for a study from January 2014 to December 2022. Initial data includes 184 FCD and 99 DNET cases. Steps: integrity of basic information (missing FCD: 52, DNET: 15), MRI image registration (missing FCD: 36, DNET: 11). Available data: 96 FCD, 73 DNET. Patients enrolled in research are divided into training cohort (119) and testing cohort (50).

Figure 1. Patient selection flowchart. The subjects were selected according to the inclusion criteria and exclusion criteria. FCD, focal cortical dysplasia; DNET, dysembryoplastic neuroepithelial tumors.

2.2 MRI datasets and preprocessing

All patients were scanned by a 3.0 T scanner (Achieva 3.0 T TX, Philips, Holland) with an 8-channel head coil, with the following scanning parameters: T1WI: repetition time (TR) = 2,000 ms and echo time (TE) = 20 ms; T2WI: TR = 3,500 ms and TE = 80 ms; T2-FLAIR: TR = 8,000 ms and TE = 125 ms. For all images, the field of view (FOV) was 230 × 191 × 143 mm, and slice thickness was 5.0 mm with an inter-slice spacing of 1.0 mm.

For image segmentation, the images of each subject were first aligned to T2-FLAIR using the FSL Version 5.0.9.1 Then they were loaded into an open-source image processing software ITK-SNAP (version 4.0.0, http://www.itksnap.org) in DICOM format. The 3D volume of the lesion was manually delineated layer by layer along its contour on T1WI, T2WI, and T2-FLAIR images by two radiologists with 8- and 5-year experience who were independently blinded to the clinical data of patients. During the delineation process, the following principles were strictly followed: (1) Boundary determination: The ROI is strictly delineated along the edge of the lesion, and the adjacent normal brain tissue is excluded as much as possible. (2) Image quality consideration: During the delineation process, actively avoid regions with significant volume effects, motion artifacts, and susceptibility artifacts that may affect the accuracy of the signal. (3) Multi-sequence collaborative judgment: The radiologist refers to the registered images of multiple sequences (such as T1WI, T2WI, and T2-FLAIR) and comprehensively determines the lesion range, ensuring that the ROI is spatially consistent across different sequences. (4) Dispute resolution mechanism: If the two radiologists have a disagreement on the delineation of a certain ROI, an experienced senior radiologist with 15 years of experience in central nervous system imaging diagnosis will arbitrate. This expert will review the registration quality and segmentation consistency of multiple sequence images one by one, and ultimately determine the ROI range to ensure that all subjects’ lesion areas are accurately and consistently covered. The intra- and interobserver agreement was assessed using the intraclass correlation coefficient (ICC), and ICC > 0.75 was considered good agreement.

In terms of image preprocessing, we have indeed carried out several steps to enhance data quality and feature stability, which include: (1) Image resampling (Resampling): All images are uniformly resampled to isotropic resolution (the default value is 1 × 1 × 1 mm3) to eliminate the influence of resolution differences among the original images on feature extraction. (2) Grayscale Discretization (Discretization): The grayscale values of the image are discretized using a fixed bin width (the default bin width is 25 HU) to reduce noise and enhance the consistency of features. (3) Image Filtering (Filtering): The default filter set of PyRadiomics was applied, including: Gaussian Laplacian (LoG) filtering and wavelet filtering. Other image enhancement filters (such as gradient, square, etc.). (4) Image mask processing: Before feature extraction, all the regions of interest (ROI) were delineated by experienced radiologists and the masks were ensured to be aligned with the images. All these preprocessing steps were completed using the default parameters of PyRadiomics. The specific settings can be referred to the IBSI guidelines and the official documentation of PyRadiomics. The whole dataset was randomly divided into a training set and a test set at a ratio of 3:1. All the cases in the training set were used to train the diagnostic model, whereas all the cases in the test set were used to independently evaluate the performance of the model.

2.3 Feature extraction and feature selection

PyRadiomics software (version 3.0, http://readthedocs.org/projects/PyRadiomics/) was used for feature extraction and feature selection. This tool strictly follows the standards of the Imaging Biomarker Standardization Initiative (IBSI), ensuring the standardization and reproducibility of feature calculations. Finally, a total of 1,130 features were extracted and categorized into seven major types: (1) 18 first-order statistics; (2) 14 shape-based; (3) 24 gray level co-occurrence matrix (GLCM); (4) 16 gray level run length matrix (GLRLM); (5) 16 gray level size zone matrix (GLSZM); (6) 5 neighboring gray tone difference matrix (NGTDM); (7) 14 gray level dependence matrix (GLDM). After normalization, feature screening was further performed using the machine learning algorithm provided by the sklearn package.

2.4 Model training and validation

The features with no significant difference between the two groups were filtered by the two-sample t-test, and the optimal features were determined using the LASSO algorithm with 5-fold cross-validation. Twenty-five, 8 and 14 feature subsets were extracted from the T1WI-, T2WI- and T2-FLAIR-based models, respectively. Then the above process was repeated to further screen the fusion features of the three, and a total of 12 fusion features were obtained finally. SVM was used for the classification of features. In the training set, GridSearchCV (CV = 5, namely, 5-fold cross-validation) was used to optimize the hyperparameters of the model to reduce its training error and generalization error. The diagnostic efficacy of the model was assessed through the mean area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and accuracy. The workflow of data preparation and radiomics analysis is shown in Figure 2.

Figure 2
Flowchart detailing steps in medical imaging analysis. It includes image acquisition (FCD and DNET scans: T1WI, T2WI, FLAIR), ROI segmentation (highlighting regions in yellow and blue), feature extraction and selection (graphs showing data split and feature trends), and model training with ROC curve evaluation, demonstrating diagnostic performance.

Figure 2. Workflow of the radiomics analysis. The workflow of the radiomics analysis was as follows: Image acquisition, ROI segmentation, feature extraction, feature selection, model training, and diagnostic performance evaluation.

2.5 Radiologists’ assessment

To compare the performance of the radiomics model with the radiologists’ assessment results in differentiating FCD from DNET, two radiologists with 8- and 5-year experience who were blinded to the clinical and pathological data were asked to differentiate FCD from DNET according to the sequences (T1WI, T2WI, and T2-FLAIR). Then the sensitivity and specificity of the radiomics model and the radiologists’ assessment results were compared.

2.6 Statistical analysis

Statistical analysis was performed using SPSS26.0. Measurement data (age, age of seizure onset) was expressed as median [interquartile range (IQR)]. Independent sample t-test (if homogeneity of variance was met) or Welch’s t-test (if heterogeneity of variance was met) was used for comparison between groups. Count data (gender, seizure type, past medical history and Number of anti-seizure medication.) were expressed as the number of cases (percentage) [n (%)], and comparison between groups was performed using the Chi-square test or Fisher’s exact test (when the expected frequency was <5). p < 0.05 was considered statistically significant.

3 Results

3.1 Patient characteristics

A total of 169 patients with FCD (n = 96) or DNET (n = 73) were included, with more males than females in both FCD and DNET groups. Among the 96 FCD patients, the histological subtypes were distributed as follows: type Ia (n = 8), type Ib (n = 11), type Ic (n = 9), type IIa (n = 32), and type IIb (n = 36). The median age at seizure onset in the FCD group was higher than that in the DNET group. 59 (61.5%) patients in the FCD group and 37 (50.7%) patients in the DNET group administer more than three kinds of anti-seizure medication. The gender, age at seizure onset, type of seizure, past medical history, and kinds of anti-seizure medication administered had no significant differences between the FCD and DNET groups (Table 1).

Table 1
www.frontiersin.org

Table 1. Clinical characteristics of patients.

3.2 Diagnostic performance of radiomics models

Three T1WI-, T2WI-, and T2-FLAIR-based models and a fusion radiomics model based on the combination of the three sequences were established. It was found that the fusion radiomics model had the best performance, with an AUC of 0.894 (95% CI, 0.799–0.968), accuracy of 82.0%, sensitivity of 92.9%, and specificity of 68.2%. For the T1WI-, T2WI- and T2-FLAIR-based models, the accuracy was 76.0, 84.0 and 76.0%, the sensitivity was 75.0, 92.9 and 75.0%, the specificity was 77.3, 72.7 and 77.2%, and the AUC was 0.816 (95% CI, 0.710–0.912), 0.864 (95% CI, 0.755–0.951) and 0.820 (95% CI, 0.705–0.91), respectively. The statistical selection process of features with the LASSO algorithm is shown in Figure 3. The AUCs of different models are shown in Figure 4.

Figure 3
Graphs depicting statistical analyses. Panel A shows line graphs with error bars highlighting trends across various scales. Panel B displays multiple line plots with diverse colors suggesting variable interactions. Panel C includes bar charts with labeled axes, indicating feature importance or contribution. Panel D features ROC curves with shaded areas, showing performance metrics and AUC values across different models.

Figure 3. Statistical selection process of radiomic features with LASSO regression. (A,B) The decreasing path of mean square deviation and characteristic coefficient with the change of λ value. (C) Features related to the optimal value were further reserved with respective coefficients to build the radiomics signature model. (D) ROC curve were cross-validated with hyperparameters on the training set in individual and fusion model.

Figure 4
Two ROC curves illustrate the performance of different imaging techniques. Panel a and panel b each show plots with four colored lines representing T2WI, T1WI, Flair, and Fusion. The x-axis is labeled FPR (False Positive Rate) and the y-axis is labeled TPR (True Positive Rate), with a diagonal line for reference.

Figure 4. The area under the ROC curve of for different models. (a) Training set and (b) test set. The gray diagonal lines indicate an AUC value of 0.5, which means the prediction result of completely random.

The image features of the fusion model are summarized as follows: T2_log-sigma-2-mm-3D_grIm_GrayLevelNonUniformityNormalized, FLAIR_wavelet-HLL_gIrlm_ShortRunLowGrayLeveEmphasis, FLAIR_wavelet-LHL_ngtdm_Contrast, T1_original_firstorder_10Percentile, T2_wavelet-LLL_glcm_SumAverage, T2_original_glcm_JointEntropy, T2_log-sigma-3-mm-3D_glcm_SumEntropy, T2_original_glcm_SumAverage, T1 log-sigma-2-mm-3D_firstorder_10Percentile, T2_original_shape_Elongation, T2_original_glcm_JointAverage, T2_wavelet-LLL_glcm_JointAverage.

3.3 Radiologists reading

The accuracy, sensitivity and specificity of the junior radiologist’s assessment were50.0, 53.6, and 45.5%, respectively, while those of the senior radiologist’s assessment were 76.0, 78.6, and 72.7%, respectively. The diagnostic performance of the fusion radiomics model was superior to that of the junior radiologist and comparable to that of the senior radiologist (Table 2). During radiologists reading, there were some easily-confused cases, which led to misdiagnosis. The representative FCD and DNET cases with similar imaging findings are shown in Figure 5.

Table 2
www.frontiersin.org

Table 2. Diagnostic performance of comparison of radiomics and human assessment.

Figure 5
MRI brain scans in four rows labeled A to D, each with three columns showing T2WI, T1WI, and FLAIR images. Blue arrows highlight specific areas of interest in each scan, indicating potential abnormalities.

Figure 5. Illustrations of MRIs for FCD and DNET. (A) FCD was presented in the left occipital lobe. (B) DNET was presented in the left frontal lobe. (C) FCD was presented in the right frontal lobe. (D) DNET was presented in the left frontal lobe. FCD, focal cortical dysplasia; DNET, dysembryoplastic neuroepithelial tumors.

4 Discussion

In this study, several MRI-based radiomics models were established to differentiate FCD from DNET. Among them, the fusion radiomics model exhibited the highest prediction accuracy, with an AUC of 0.894. Importantly, the diagnostic performance of the fusion radiomics model was superior to that of the junior radiologist and comparable to that of the senior radiologist, suggesting its clinical application value. To the best of our knowledge, this is the first time that an MRI-based radiomics model is used for the differential diagnosis of FCD and DNET, the two most common epileptogenic lesions in children. Given the different surgical strategies and prognosis between FCD and DNET, this model is expected to provide a new method for preoperative differential diagnosis.

A total of 12 features were extracted in this study, mainly including 2 first-order features, 11 shape features, 6 gray-level co-occurrence matrix (GLCM) features, 2 gray-level run-length matrix (GLRLM) features, 4 wavelet features, and 3 log-sigma features. The shape features are used to describe the geometric features of the image, providing quantifiable indicators for morphological analysis of tumors. GLCM features, GLRLM features, and log-sigma features reflect the image texture, describing the pixel spatial distribution. Since texture can make full use of image information, it serves as an important basis for image description and recognition. It is challenging to recognize these features by visual perception, but they offer valuable insights into the tumor cell structure and microenvironment, providing powerful evidence for differentiation of DNET and FCD (21). Texture outperforms other image features by effectively capturing both the global properties and intricate details of the image. The wavelet features can effectively capture the image texture information of various scales, thereby providing valuable information for the differentiation and classification of lesions. They exhibit a strong ability of prognostic evaluation and serve as crucial components in radiomics modeling (22). In addition, first-order features are used to describe the distribution of grayscale value within an image for the differentiation and classification of lesions.

Radiomics features have been widely used in radiomics research, which display good performance in the differentiation of lesions. They combine many features of the image and allow a more comprehensive analysis, resulting in higher sensitivity and accuracy in lesion diagnosis than a few or a single image indicator (18). The concept of radiomics originates from medical imaging but surpasses it in terms of complexity and scope. It has drawn great attention in various domains such as image recognition and data analysis. Transforming the image into multidimensional quantitative data has emerged as a valuable tool to contribute to clinical decision-making (23), which can differentiate two similar diseases by extracting their features, greatly improving preoperative diagnostic accuracy and providing a useful reference for surgical planning. In this study, the radiomics model exhibited superior performance in differentiating between FCD and DNET. This model makes accurate preoperative differentiation of FCD and DNET among epilepsy patients feasible, allowing clinicians to effectively tailor surgical plans for better outcomes and quality of life.

Our research ultimately identified these 12 features as describing a highly heterogeneous tumor image: Firstly, multiple texture features such as GrayLevelNonUniformity, Contrast, JointEntropy, and SumEntropy all point to a chaotic internal structure of the tumor, possibly containing various components (such as active tumor, necrosis, and edema); Secondly, multiple intensity-related features on T2 and FLAIR, such as SumAverage, JointAverage, and ShortRunLowGrayLevelEmphasis, suggest that there may be extensive edema and necrotic areas within the tumor; Thirdly, the `Elongation` feature indicates that the tumor has an irregular shape and grows in an infiltrative manner rather than in a clearly demarcated expansive way. Finally, the features are derived from multiple sequences including T1, T2, and FLAIR, and even different processing methods of the same sequence (original, wavelet, LoG filtering), which allows the model to comprehensively evaluate the two diseases from multiple perspectives (cell density, water content, edges, and different scales), suggesting that FCD and DNET have completely different pathological features internally. This radiomics model can help distinguish between these two diseases, which is crucial for the selection of treatment plans and the assessment of treatment effects.

In addition, radiomics can serve as a supplementary approach to certain challenges encountered by radiologists. Frequent work interruption is associated with increased time consumption and an increased likelihood of errors (24). Moreover, some cognitive biases may adversely affect the diagnostic accuracy (25). Radiomics possesses significant advantages in reducing reporting time and cognitive biases, especially for junior radiologists lacking relevant experience (26). However, current radiomics strategies involve excessive post-processing before establishing appropriate machine learning models, and more studies on the effect-cost balance of such machine learning systems are needed before their clinical application.

In previous studies on childhood diseases, MR sequences with long scanning time were used (27), which was quite time-consuming and harmed the physical and mental health of patients. For younger children who cannot fully cooperate, there are certain difficulties in image acquisition, and the image quality cannot meet the requirements. Considering the high dose of anesthetic drugs, the impact on the brain development of children cannot be estimated. Besides, the longer the scanning time, the worse the compliance of children with claustrophobia, and the image quality also presents difficulties to radiologists and even fails to meet the diagnostic requirements (28).

For the above reasons, conventional MRI images were used in this study, which not only meet ethical requirements but also reduce the physical and mental burden of children.

To the best of our knowledge, few studies are available on the differential diagnosis of FCD and DNET in child patients with epilepsy. Previous studies using DTI parameters to evaluate the changes of white matter surrounding epileptogenic foci suggested that only mean diffusivity may be useful in the differentiation of DNET from FCD, and this conclusion was based on the premise that the lesions showed hyperintensity on T2 and T2-FLAIR (29), which largely limited the inclusion of cases. The findings of this study may provide a reference for future research on this population. In the case of FCD, neurosurgeons can perform wide cortical resection over the MRI-delineated lesion, which can help reduce the incidence of postoperative epilepsy in patients with FCD. Furthermore, having a thorough understanding of the possible postoperative outcomes may increase the doctor-patient trust during epilepsy surgery.

This study still had some limitations. Firstly, the sample size was small, and the dataset was collected from one local tertiary hospital. In the future, a prospective multicenter study with a larger sample size should be conducted. Secondly, only T1WI, T2WI, and T2-FLAIR images were used, so multi-modal imaging data need to be included in the future, such as diffusion-weighted imaging (DWI) and arterial spin labeling. Thirdly, the diagnostic efficacy of radiomics models is related to the fusion features, so more features should be considered to achieve better performance.

In conclusion, a cost-effective, convenient, and non-invasive fusion radiomics model was established based on multiple features from conventional MRI images (T1WI, T2WI, and T2-FLAIR) to effectively differentiate between FCD and DNET in child patients with epilepsy before surgery. This model holds significant potential as a valuable reference for surgical planning and contributes to clinical practice.

Data availability statement

The datasets presented in this article are not readily available because due to the limitations of the ethics committee database. Requests to access the datasets should be directed to Xinyi Yang; eGlueWltc3VAMTYzLmNvbQ==.

Ethics statement

The studies involving humans were approved by The Institutional Review Board of Children’s Hospital of Chongqing Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because this study is a retrospective study.

Author contributions

XY: Writing – review & editing, Data curation, Validation, Conceptualization, Software, Methodology, Writing – original draft. SD: Formal analysis, Data curation, Validation, Investigation, Software, Writing – original draft, Writing – review & editing, Conceptualization. ZH: Software, Investigation, Writing – review & editing, Conceptualization, Methodology, Validation, Formal analysis, Data curation, Supervision. XZ: Supervision, Project administration, Validation, Writing – review & editing, Formal analysis, Software, Data curation, Conceptualization. JC: Formal analysis, Visualization, Supervision, Project administration, Software, Data curation, Investigation, Validation, Conceptualization, Methodology, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

References

1. Bast, T, Ramantani, G, Seitz, A, and Rating, D. Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults. Acta Neurol Scand. (2006) 113:72–81. doi: 10.1111/j.1600-0404.2005.00555.x

PubMed Abstract | Crossref Full Text | Google Scholar

2. Piao, YS, Lu, DH, Chen, L, Piao, Y‐S, Lu, D‐H, Liu, J, et al. Neuropathological findings in intractable epilepsy: 435 Chinese cases. Brain Pathol. (2010) 20:902–8. doi: 10.1111/j.1750-3639.2010.00386.x

PubMed Abstract | Crossref Full Text | Google Scholar

3. Luzzi, S, Elia, A, Del Maestro, M, Elbabaa, SK, Carnevale, S, Guerrini, F, et al. Dysembryoplastic Neuroepithelial tumors: what you need to know. World Neurosurg. (2019) 127:255–65. doi: 10.1016/j.wneu.2019.04.056

Crossref Full Text | Google Scholar

4. Kim, DW, Lee, SK, Chu, K, Park, KI, Lee, SY, Lee, CH, et al. Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia. Neurology. (2009) 72:211–6. doi: 10.1212/01.wnl.0000327825.48731.c3

PubMed Abstract | Crossref Full Text | Google Scholar

5. Englot, DJ, Berger, MS, Barbaro, NM, and Chang, EF. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia. (2012) 53:51–7. doi: 10.1111/j.1528-1167.2011.03269.x

PubMed Abstract | Crossref Full Text | Google Scholar

6. Krsek, P, Maton, B, Jayakar, P, Dean, P, Korman, B, Rey, G, et al. Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology. (2009) 72:217–23. doi: 10.1212/01.wnl.0000334365.22854.d3

PubMed Abstract | Crossref Full Text | Google Scholar

7. O'Brien, DF, Farrell, M, Delanty, N, Traunecker, H, Perrin, R, Smyth, MD, et al. The children's Cancer and Leukaemia group guidelines for the diagnosis and management of dysembryoplastic neuroepithelial tumours. Br J Neurosurg. (2007) 21:539–49. doi: 10.1080/02688690701594817

PubMed Abstract | Crossref Full Text | Google Scholar

8. Rácz, A, Müller, AM, Schwerdt, J, Becker, A, Vatter, H, and Elger, CE. Age at epilepsy onset in patients with focal cortical dysplasias, gangliogliomas and dysembryoplastic neuroepithelial tumours. Seizure. (2018) 58:82–9. doi: 10.1016/j.seizure.2018.04.002

PubMed Abstract | Crossref Full Text | Google Scholar

9. Rheims, S, Rubi, S, Bouvard, S, Bernard, E, Streichenberger, N, Guenot, M, et al. Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [11C]methionine PET. Neuro-Oncology. (2014) 16:1417–26. doi: 10.1093/neuonc/nou022

PubMed Abstract | Crossref Full Text | Google Scholar

10. Gillies, RJ, Kinahan, PE, and Hricak, H. Radiomics: images are more than pictures, they are data. Radiology. (2016) 278:563–77. doi: 10.1148/radiol.2015151169

PubMed Abstract | Crossref Full Text | Google Scholar

11. Yip, SS, and Aerts, HJ. Applications and limitations of radiomics. Phys Med Biol. (2016) 61:R150–66. doi: 10.1088/0031-9155/61/13/R150

PubMed Abstract | Crossref Full Text | Google Scholar

12. Gombolay, GY, Gopalan, N, Bernasconi, A, Nabbout, R, Megerian, JT, Siegel, B, et al. Review of machine learning and artificial intelligence (ML/AI) for the pediatric neurologist. Pediatr Neurol. (2023) 141:42–51. doi: 10.1016/j.pediatrneurol.2023.01.004

PubMed Abstract | Crossref Full Text | Google Scholar

13. Bi, WL, Hosny, A, Schabath, MB, Giger, ML, Birkbak, NJ, Mehrtash, A, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. (2019) 69:127–57. doi: 10.3322/caac.21552

PubMed Abstract | Crossref Full Text | Google Scholar

14. Huang, TM, and Kecman, V. Gene extraction for cancer diagnosis by support vector machines--an improvement. Artif Intell Med. (2005) 35:185–94. doi: 10.1016/j.artmed.2005.01.006

PubMed Abstract | Crossref Full Text | Google Scholar

15. Qian, Z, Li, Y, Wang, Y, Li, L, Li, R, Wang, K, et al. Differentiation of glioblastoma from solitary brain metastases using radiomic machine-learning classifiers. Cancer Lett. (2019) 451:128–35. doi: 10.1016/j.canlet.2019.02.054

PubMed Abstract | Crossref Full Text | Google Scholar

16. Han, H, and Jiang, X. Overcome support vector machine diagnosis overfitting. Cancer Inform. (2014) 13:145–58. Published 2014 Dec 9. doi: 10.4137/CIN.S13875

PubMed Abstract | Crossref Full Text | Google Scholar

17. Tan, YL, Kim, H, Lee, S, Tihan, T, ver Hoef, L, Mueller, SG, et al. Quantitative surface analysis of combined MRI and PET enhances detection of focal cortical dysplasias. NeuroImage. (2018) 166:10–8. doi: 10.1016/j.neuroimage.2017.10.065

PubMed Abstract | Crossref Full Text | Google Scholar

18. Moons, KG, Altman, DG, Reitsma, JB, Ioannidis, JP, Macaskill, P, Steyerberg, EW, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. (2015) 162:W1–W73. doi: 10.7326/M14-0698

PubMed Abstract | Crossref Full Text | Google Scholar

19. Qian, Z, Zhang, L, Hu, J, Chen, S, Chen, H, Shen, H, et al. Machine learning-based analysis of magnetic resonance Radiomics for the classification of Gliosarcoma and glioblastoma. Front Oncol. (2021) 11:699789. doi: 10.3389/fonc.2021.699789

PubMed Abstract | Crossref Full Text | Google Scholar

20. Blümcke, I, Thom, M, Aronica, E, Armstrong, DD, Vinters, HV, Palmini, A, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. (2011) 52:158–74. doi: 10.1111/j.1528-1167.2010.02777.x

PubMed Abstract | Crossref Full Text | Google Scholar

21. Gore, S, Chougule, T, Jagtap, J, Saini, J, and Ingalhalikar, M. A review of Radiomics and deep predictive modeling in glioma characterization. Acad Radiol. (2021) 28:1599–621. doi: 10.1016/j.acra.2020.06.016

PubMed Abstract | Crossref Full Text | Google Scholar

22. Park, CJ, Choi, YS, Park, YW, Ahn, SS, Kang, SG, Chang, JH, et al. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status. Neuroradiology. (2020) 62:319–26. doi: 10.1007/s00234-019-02312-y

PubMed Abstract | Crossref Full Text | Google Scholar

23. Lambin, P, Rios-Velazquez, E, Leijenaar, R, Carvalho, S, van Stiphout, RGPM, Granton, P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. (2012) 48:441–6. doi: 10.1016/j.ejca.2011.11.036

PubMed Abstract | Crossref Full Text | Google Scholar

24. Williams, LH, and Drew, T. Distraction in diagnostic radiology: how is search through volumetric medical images affected by interruptions? Cogn Res Princ Implic. (2017) 2:12. doi: 10.1186/s41235-017-0050-y

PubMed Abstract | Crossref Full Text | Google Scholar

25. Lee, CS, Nagy, PG, Weaver, SJ, and Newman-Toker, DE. Cognitive and system factors contributing to diagnostic errors in radiology. AJR Am J Roentgenol. (2013) 201:611–7. doi: 10.2214/AJR.12.10375

PubMed Abstract | Crossref Full Text | Google Scholar

26. Thrall, JH, Li, X, Li, Q, Cruz, C, do, S, Dreyer, K, et al. Artificial intelligence and machine learning in radiology: opportunities, challenges, pitfalls, and criteria for success. J Am Coll Radiol. (2018) 15:504–8. doi: 10.1016/j.jacr.2017.12.026

PubMed Abstract | Crossref Full Text | Google Scholar

27. Colon, AJ, van Osch, MJ, Buijs, M, Grond, JV, Boon, P, van Buchem, MA, et al. Detection superiority of 7 T MRI protocol in patients with epilepsy and suspected focal cortical dysplasia. Acta Neurol Belg. (2016) 116:259–69. doi: 10.1007/s13760-016-0662-x

PubMed Abstract | Crossref Full Text | Google Scholar

28. Goo, HW. Whole-body MRI in children: current imaging techniques and clinical applications. Korean J Radiol. (2015) 16:973–85. doi: 10.3348/kjr.2015.16.5.973

PubMed Abstract | Crossref Full Text | Google Scholar

29. Rau, A, Kellner, E, Foit, NA, Lützen, N, Heiland, DH, Schulze-Bonhage, A, et al. Discrimination of epileptogenic lesions and perilesional white matter using diffusion tensor magnetic resonance imaging. Neuroradiol J. (2019) 32:10–6. doi: 10.1177/1971400918813991

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: focal cortical dysplasia, dysembryoplastic neuroepithelial tumor, epilepsy, radiomics, magnetic resonance imaging

Citation: Yang X, Ding S, Huang Z, Zhang X and Cai J (2025) MRI-based radiomics model for differentiating focal cortical dysplasia from dysembryoplastic neuroepithelial tumor in epileptic children. Front. Neurol. 16:1658440. doi: 10.3389/fneur.2025.1658440

Received: 07 July 2025; Accepted: 03 November 2025;
Published: 13 November 2025.

Edited by:

Daichi Sone, Jikei University School of Medicine, Japan

Reviewed by:

Iman Beheshti, University of Manitoba, Canada
Shan Wang, Zhejiang University, China

Copyright © 2025 Yang, Ding, Huang, Zhang and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jinhua Cai, Y2FpX2ppbmh1YUAxMjYuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.